Elsevier

Brain Research

Volume 1397, 23 June 2011, Pages 28-37
Brain Research

Research Report
The brainstem preproglucagon system in a non-human primate (Macaca mulatta)

https://doi.org/10.1016/j.brainres.2011.05.002Get rights and content

Abstract

The nucleus of the solitary tract (NTS) contains a small population of neurons expressing preproglucagon. In these neurons preproglucagon is processed to the glucagon-like-peptides 1 and 2 (GLP-1 and GLP-2) and oxyntomodulin. Whereas the neuroanatomy of these neurons is well characterized in rodents the location and projection of preproglucagon neurons have never been described in primates. The purpose of the present study was to characterize the location of preproglucagon neurons and their projections in the non-human primate using radioactive in situ hybridization and immunohistochemistry. In situ hybridization revealed preproglucagon mRNA expressing neurons in the caudal nucleus of the solitary tract extending laterally through the intermediate reticular nucleus into the A1 area. Using an antibody raised against rat GLP-2, GLP-2-immunoreactive (− ir) cell bodies were found in the same areas as the preproglucagon mRNA. Only very few GLP-2-ir nerve fibers were observed in the caudal brainstem and mostly in the same areas as the GLP-2-ir cell bodies. The most prominent GLP-2-ir terminal fields were detected in the hypothalamus and rostrally in the bed nucleus of the stria terminalis complex. In the hypothalamus, GLP-2-ir fibers arborized extensively in the paraventricular nucleus of the hypothalamus (PVN), the dorsomedial hypothalamic nucleus (DMH) and the arcuate nucleus (Arc), the latter containing the densest fiber-plexus. The findings indicate that the brainstem preproglucagon neuronal system is highly conserved between rat and non-human primate with the exception of a much denser innervation of the mediobasal hypothalamus in the primate brain.

Research highlights

► First report of preproglucagon expression and GLP-ir in the primate brain. ► Most comprehensive study of NTS-hypothalamus projections in the primate. ► Data indicate important species differences in brainstem–hypothalamus projections.

Introduction

The proglucagon derived peptides Glucagon-like-peptides 1 and 2 (GLP-1 and GLP-2) and oxyntomodulin are all members of the brain–gut peptides that include cholecystokinin (CCK) and peptide YY (PYY). In the periphery, preproglucagon is expressed in pancreatic α-cells where the predominant post-translational form is glucagon and flanking peptides (Holst et al., 1994) and in L-cells of the intestine where post-translational processing gives rise to GLP-1, GLP-2 and smaller amounts of glicentin and oxyntomodulin (Drucker, 1998, Holst, 2007). In response to gut lumen nutrients the endocrine L-cells release a cocktail of peptides including GLP-1, GLP-2, oxyntomodulin and PYY (Tolhurst et al., 2009). Peripherally secreted GLP-1 is believed to bind and activate GLP-1 receptors located in the pancreas, on afferent vagal nerve-endings, and possibly also GLP-1 receptors in the caudal brainstem/hypothalamus, areas playing an important role in the regulation of glucose homeostasis, gastrointestinal motility and appetite (Holst, 2007, Vrang and Larsen, 2010b, Wettergren et al., 1993, Williams et al., 2009).

Preproglucagon expression has also been detected in the brain, but limited to a rather small population of neurons located in the nucleus of the solitary tract and extending laterally into the A1 area (Drucker and Asa, 1988, Jin et al., 1988). These neurons process preproglucagon as L-cells and hence produce GLP-1, GLP-2, oxyntomodulin and glicentin (Larsen et al., 1997). Since preproglucagon expression in the brain is limited to the NTS/A1 area, it has been possible to investigate the efferent projections of these neurons by immunocytochemistry using antibodies raised against proglucagon or proglucagon-derived peptides (Jin et al., 1988, Larsen et al., 1997, Rinaman, 1999a, Vrang et al., 2007). These studies have collectively shown that the brainstem preproglucagon neurons project predominantly rostrally with main terminal fields in hypothalamic areas involved in appetite regulation including the hypothalamic paraventricular (PVN), dorsomedial (DMH) and arcuate (Arc) nuclei (Jin et al., 1988, Larsen et al., 1997, Rinaman, 1999a, Vrang et al., 2007). The areas contain GLP-1 (PVN, DMH and Arc) and GLP-2 (DMH) receptor mRNA (Merchenthaler et al., 1999, Tang-Christensen et al., 2000). In line with the anatomical location of GLP-1 and GLP-2 receptors it has been demonstrated by a number of groups that central administration of either GLP-1, GLP-2 or oxyntomodulin reduces food intake (Dakin et al., 2001, Tang-Christensen et al., 1996, Tang-Christensen et al., 1998, Tang-Christensen et al., 2000, Turton et al., 1996).

Although it is generally accepted that the CNS preproglucagon systems plays a role in appetite regulation, the physiological role is still debated. Located in the NTS the preproglucagon neurons can be activated by vagal afferents. Hence, gastric balloon distension, mimicking gastric distension in response to a meal has been shown to activate preproglucagon neurons in the NTS and adjacent lateral reticular formation (Vrang et al., 2003) and central GLP-1R blockade can block the feeding inhibitory effect of gastric distension (Hayes et al., 2009) suggesting that NTS GLP-1 signalling is engaged by gastric satiation signals. In a recent study in transgenic mice expressing the fluorophore Venus under the control of the preproglucagon promoter,Hisadome et al.(2010) elegantly demonstrated that preproglucagon neurons are activated by vagal afferents and are directly activated by leptin. In further support of vagal-to-preproglucagon-neuron signaling is the findings that interoceptive stressors believed to engage vagal afferent signaling stimulation such as that caused by certain interoceptive stressors (e.g. intraperitoneal administration of LiCl, lipopolysaccharide and high doses of CCK) have been shown to activate central preproglucagon neurons (Rinaman, 1999a). In support of GLP-1 as a mediator of LiCl induced anorexia and taste aversion, both can be significantly blunted by GLP-1 receptor antagonists (Rinaman, 1999b, Seeley et al., 2000).

While the central preproglucagon system has been extensively studied in the rodent, it is unknown if this system is conserved in primates and the presence of a central preproglucagon system has yet to be reported. The purpose of this study was to characterize the distribution of preproglucagon expressing neurons and their projections in a nonhuman primate.

Section snippets

Results

In the rat, preproglucagon mRNA was found in the nucleus of the solitary tract (NTS) as well as in the reticular formation extending laterally and ventrally from the NTS-proper into the A1 area (Fig. 1). This pattern is identical to what has been reported previously using in situ hybridization (Merchenthaler et al., 1999) and immunohistochemical methods (Jin et al., 1988, Larsen et al., 1997, Rinaman, 1999a). In the monkey brainstem a very similar pattern of preproglucagon expression was

Discussion

In the present study we describe for the first time the brainstem preproglucagon system in a non-human primate: Macaca mulatta. As observed in rodents (Larsen et al., 1997, Merchenthaler et al., 1999) centrally located preproglucagon expressing neurons are confined to the nucleus of the solitary tract and in the lateral reticular formation extending from the NTS-proper laterally towards the A1 area. Overall the organization of the brainstem preproglucagon system appears to be very similar

Animals and surgery

All experiments were conducted in accordance with internationally accepted principles for the care and use of laboratory animals and were approved by the Oregon National Primate Research Center Institutional Animal Care and Use Committee (Macaca mulatta) and the Danish committee for animal research (rats).

Monkey tissue (for in situ hybridization and immunohistochemistry)

Two (2) 8 year old adult male Rhesus macaque monkeys (Macaca mulatta) were used. The monkeys were housed in outdoor corrals and maintained on a commercial monkey chow diet (Ralston Purina, St.

Acknowledgments

This study was supported by The Danish Diabetes Association, The Novo Nordisk Foundation and Fonden til Lægevidenskabens Fremme. We thank Anja Daniel Andersen for excellent technical assistance. We also thank NCRRfor supporting this study (grant R000163) (KLG).

References (44)

  • P.E. Sawchenko et al.

    The organization of noradrenergic pathways from the brain stem to the paraventricular and supraoptic nuclei in the rat

    Brain Res. Rev.

    (1982)
  • N. Vrang et al.

    Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei

    Brain Res.

    (2007)
  • N. Vrang et al.

    Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides

    Prog. Neurobiol.

    (2010)
  • N. Vrang et al.

    Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides

    Prog Neurobiol.

    (2010)
  • R.E. Watson et al.

    Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology

    Peptides

    (1986)
  • R.M. Beckstead et al.

    The nucleus of the solitary tract in the monkey: projections to the thalamus and brain stem nuclei

    J. Comp. Neurol.

    (1980)
  • H.R. Berthoud

    Homeostatic and non-homeostatic pathways involved in the control of food intake and energy balance

    Obesity (Silver Spring)

    (2006)
  • H.R. Berthoud

    Vagal and hormonal gut–brain communication: from satiation to satisfaction

    Neurogastroenterol. Motil.

    (2008)
  • E.T. Cunningham et al.

    A circumscribed projection from the nucleus of the solitary tract to the nucleus ambiguus in the rat: anatomical evidence for somatostatin-28-immunoreactive interneurons subserving reflex control of esophageal motility

    J. Neurosci.

    (1989)
  • C.L. Dakin et al.

    Oxyntomodulin inhibits food intake in the rat

    Endocrinology

    (2001)
  • D.J. Drucker

    Glucagon-like peptides

    Diabetes

    (1998)
  • M.M. Glavas et al.

    Characterization of brainstem peptide YY (PYY) neurons

    J. Comp. Neurol.

    (2008)
  • Cited by (25)

    • A Cre-driver rat model for anatomical and functional analysis of glucagon (Gcg)-expressing cells in the brain and periphery

      2022, Molecular Metabolism
      Citation Excerpt :

      Gcg-expressing hindbrain neurons are GLP1-immunopositive, are sensitive to metabolic state, project to multiple subcortical regions of the central nervous system (CNS), and are implicated in neuroendocrine, autonomic, and behavioral responses to cognitive and physical stressors [8–14]. Gcg-expressing and/or GLP1-positive cells in the pancreas, intestine, and hindbrain are similarly distributed in rodents and primates, including humans [1,15–17], and a recent genomic characterization of Gcg and related receptor genes suggests a high degree of functional conservation across mammalian species [18]. Current knowledge regarding the structure and function of Gcg-expressing cells is based largely on preclinical research using rodent models, with especially valuable contributions arising from experiments using transgenic mice to visualize and manipulate Gcg-expressing cells with a high degree of anatomical and cellular specificity [19–25].

    • GLP-1 modulates the supramammillary nucleus-lateral hypothalamic neurocircuit to control ingestive and motivated behavior in a sex divergent manner

      2019, Molecular Metabolism
      Citation Excerpt :

      The GLP-1R expression in the SuM is likely complemented by direct delivery of the endogenous brain-produced GLP-1, since a previous study identified preproglucagon immunoreactive fibers in the SuM of a rat, and, interestingly, this immunoreactivity was stronger in the SuM compared to the neighboring VTA [41]. While GLP-1 immunoreactive cells and fibers have been identified in the brain of human [15] and non-human primates [42], with a great degree of overlap indicated between the rodent and primate data, to the best of our knowledge, the SuM has not yet been evaluated in primate studies. However, as recently indicated by the group of Kanoski and colleagues [43] endogenous GLP-1 can also be delivered to sites quite distal of the nucleus of the solitary tract (e.g. hippocampus) via the cerebrospinal fluid (volume transmission).

    • Extrapancreatic glucagon: Present status

      2019, Diabetes Research and Clinical Practice
      Citation Excerpt :

      In the early 1980s proglucagon amino acid sequences from cDNAs and gene sequences were isolated from the anglerfish, rat, hamster, cattle and humans [30] and revealed how the mammalian preproglucagons all contained not only the sequence of glucagon and glicentin, but also two additional glucagon-like peptides, namely, glucagon-like peptide 1 (GLP-1) and glucagon-like peptide 2 (GLP-2) separated from glucagon by two small intervening peptides I and II, respectively (Fig. 1). From RNA analyses it became evident that the glucagon gene is transcribed in the pancreatic alpha cells, in a discrete set of neurons within the nucleus of the solitary tract and in specific enteroendocrine cells of the gut (L cells) [31–35]. While the proglucagon mRNA transcripts are the same in these tissues, specific posttranslational processing results in secretion of peptides structurally related, but with very different effects [36].

    • Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain

      2015, Molecular Metabolism
      Citation Excerpt :

      A recent study even reported a reduction in food intake upon injection of Ex-4 into the hippocampus [45]. However, in the absence of any clear innervation with GLP-1 containing axons from PPG neurons in rodents or primates [1,23,26], it is difficult to imagine the source of GLP-1 in hippocampus. Nevertheless, whilst non-human primates do not seem to express GLP-1R in hippocampus [15], both in situ hybridisation and the current study identify GLP-1R in parts of the hippocampus of rat and mouse, respectively [14].

    • The gut hormone glucagon-like peptide-1 produced in brain: Is this physiologically relevant?

      2013, Current Opinion in Pharmacology
      Citation Excerpt :

      Although a small number of studies on the GLP-1 system have highlighted differences between mouse and rat [4,5] for most aspects they appear to be equivalent, and in this review we have treated studies on either as comparable. Furthermore, given that the amino acid sequence of GLP-1 is conserved throughout mammalian species [6] and that the distribution of PPG neurons in the non-human primate Macaca mulatta [7] is strikingly similar to that in rodents we make the assumption that most of these findings have clear relevance for GLP-1 action in man. At present it is still controversial as to how the central GLP-1 system is linked to peripheral post-prandial GLP-1 release and whether gut-derived GLP-1 can enter the brain to a sufficient extent to activate central GLP-1 receptors (reviewed in [3,8,9]).

    View all citing articles on Scopus
    View full text